SG Americas Securities’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$96K Buy
80,139
+41,226
+106% +$50.2K ﹤0.01% 2945
2025
Q4
$38K Buy
38,913
+24,013
+161% +$28.8K ﹤0.01% 3398
2025
Q3
$19K Sell
14,900
-37,702
-72% -$40.6K ﹤0.01% 3291
2025
Q2
$59K Buy
52,602
+18,100
+52% +$21K ﹤0.01% 2742
2025
Q1
$27K Sell
34,502
-10,372
-23% -$12.7K ﹤0.01% 3350
2024
Q4
$74K Buy
44,874
+10,511
+31% +$26.5K ﹤0.01% 2823
2024
Q3
$120K Sell
34,363
-2,009
-6% -$7.82K ﹤0.01% 2916
2024
Q2
$119K Sell
36,372
-1,084
-3% -$4.75K ﹤0.01% 2446
2024
Q1
$275K Sell
37,456
-53,097
-59% -$329K ﹤0.01% 1747
2023
Q4
$339K Buy
90,553
+16,911
+23% +$39.9K ﹤0.01% 1732
2023
Q3
$156K Buy
+73,642
New +$244K ﹤0.01% 2472
2023
Q2
Sell
-11,000
Closed -$63K 2555
2023
Q1
$63K Buy
+11,000
New +$66.4K ﹤0.01% 3026
2022
Q3
Sell
-13,076
Closed -$324K 3293
2022
Q2
$324K Sell
13,076
-91,629
-88% -$2.53M ﹤0.01% 2335
2022
Q1
$4.06M Sell
104,705
-315,485
-75% -$12.2M 0.04% 513
2021
Q4
$24.6M Buy
420,190
+363,576
+642% +$20.6M 0.16% 109
2021
Q3
$3.36M Buy
56,614
+3,543
+7% +$278K 0.02% 830
2021
Q2
$4.61M Buy
53,071
+35,372
+200% +$2.85M 0.02% 634
2021
Q1
$1.46M Buy
17,699
+14,820
+515% +$1.42M 0.01% 1266
2020
Q4
$262K Sell
2,879
-74,392
-96% -$4.62M ﹤0.01% 2464
2020
Q3
$3.09M Buy
77,271
+72,860
+1,652% +$2.54M 0.03% 520
2020
Q2
$151K Sell
4,411
-21,024
-83% -$627K ﹤0.01% 3095
2020
Q1
$565K Buy
+25,435
New +$643K 0.01% 1750
2019
Q2
Sell
-9,637
Closed -$169K 3184
2019
Q1
$169K Buy
+9,637
New +$152K ﹤0.01% 2687
2017
Q4
Sell
-10,596
Closed -$42K 3327
2017
Q3
$42K Buy
+10,596
New +$36K ﹤0.01% 3341

Other funds holding FATE